期刊文献+

扩展高频在地中海贫血患者早期听损伤检测中的应用 被引量:1

The application of extended high frequency audiometry in detecting the early hearing loss for thalassemia
原文传递
导出
摘要 目的:初步探讨扩展高频用于评估地中海贫血患者早期听损伤的临床意义。方法:对2013-09-2014-11期间在我院接受治疗的60例(117耳)地中海贫血患者进行纯音测听(常规频率加扩展高频),观察治疗前后的听力改变情况。结果:60例(117耳)地中海贫血患者治疗前后的纯音听阈分别为(15.72±11.62)dBHL和(15.40±12.24)dBHL,差异无统计学意义(P>0.05);治疗后未检出率较治疗前升高,以18、19kHz最为明显,差异有统计学意义(P<0.05)。结论:扩展高频对地贫患者早期听损伤监测较常频听可能更敏感。 Objective:To preliminarily explore the clinical significance of extended high frequency audiometry in evaluating the early hearing loss for thalassemia.Method:Pure tone audiometry(PTA)included conventional pure tone audiometry and extended high frequency audiometry were obtained on the pre and post-treatment day in60(117ears)patients from September in 2013 to October in 2014.Result:The averages of conventional pure tone audiometry for 117 cases were(15.72±11.62)dBHL on the pre-treatment day and(15.40±12.24)dBHL on the post-treatment day.There were no significant differences in PTA(P〉0.05).But the hearing without detection rate was higher than before especially at 18 and 19kHz.The differences of the hearing without detection rate between the pre-treatment and the post-treatment day were statistically significant(P〈0.05).Conclusion:The extended high frequency may be more sensitive in evaluating the early hearing loss for thalassemia.
出处 《临床耳鼻咽喉头颈外科杂志》 CAS 北大核心 2016年第10期795-797,共3页 Journal of Clinical Otorhinolaryngology Head And Neck Surgery
关键词 扩展高频 地中海贫血 早期听损失 extended high frequency thalassemia the early hearing loss
  • 相关文献

参考文献12

二级参考文献45

  • 1张连山.耳鼻咽喉科学[A]..高级医师案头丛书[C].北京:中国协和医科大学出版社,2001.176—178.
  • 2胡亚美.诸福堂实用儿科学[M].第五版.北京:人民卫生出版社,2002:1766.
  • 3Britton RS,Leicester KL,Bacon BR.Iron toxicity and chelation therapy[J].Int J Hematol,2002,76(3):220-221.
  • 4Alan R Cohen,Renzo Galanello,Dudley J Pennell,et al.Thalas-semia[J].Hematology Am Soc Hematol Educ Program,2004VN:14-34.
  • 5Atiq M,Balia M,Ahmed US.Cardiac disease in beta-thalas-saemia major:is it reversiblel[J].Singapore Med J,2006,47(8):693-695.
  • 6MA Tanner,R Galanello,C Dessi,et al.The Effect of Combined Therapy with Deferoxamine and Deferiprone on Myocardial Iron in Thalassemia[J].Circulation,2007,115:1876-1884.
  • 7De Sanctis V.Growth and puberty and its management in thalassaemia[J].Horm Res,2002,58 (Suppl 1):72-79.
  • 8Heshmat Moayeri,Zohreh Oloomi.Prevalence of Growth and Puberty Failure with Respect to Growth Hormone and Gonado-tropins Secretion in Beta-Thalassemia Major[J].Arch Iran Med,2006,9(4):331-333.
  • 9C Roth á A,Pekrun á M,Bartz á H,et al.Short stature and failure of pubertal development in thalassaemia major:evidence for hypothalamic neurosecretory dysfunction of growth hormone secretion and defective pituitary gonadotropin secretion[J].Eur J Pediatr,1997,156:778-781.
  • 10Al-Rimawi HS,Jallad MF,Amarin ZO,et al.Hypothalamic-pituitary-gonadal function in adolescent females with beta-thalassemia major[J].Int J Gynaecol Obstet,2005,90(1):44-46.

共引文献24

同被引文献3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部